| e71 |
Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
Dimitrios Nasioudis, Eloise Chapman-Davis, Melissa K. Frey, Steven S. Witkin, Kevin HolcombDimitrios Nasioudis, Eloise Chapman-Davis, Melissa K. Frey, Steven S. Witkin, Kevin Holcomb
KMSID: 1093858 J Gynecol Oncol. 2017;28(6):e71. Published online 2017 November 4 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e71 |
|
| e72 |
Fear of cancer recurrence and its predictors among cervical cancer survivorsFear of cancer recurrence and its predictors among cervical cancer survivors
Jitti Hanprasertpong, Alan Geater, Ingporn Jiamset, Laaong Padungkul, Phongchawee Hirunkajonpan, Nartya SonghongJitti Hanprasertpong, Alan Geater, Ingporn Jiamset, Laaong Padungkul, Phongchawee Hirunkajonpan, Nartya Songhong
KMSID: 1093859 J Gynecol Oncol. 2017;28(6):e72. Published online 2017 July 17 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e72 |
|
| e73 |
External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinomaExternal validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
Jung-Yun Lee, Young Shin Chung, Kiyong Na, Hye Min Kim, Cheol Keun Park, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim, Hyun-Soo KimJung-Yun Lee, Young Shin Chung, Kiyong Na, Hye Min Kim, Cheol Keun Park, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim, Hyun-Soo Kim
KMSID: 1093860 J Gynecol Oncol. 2017;28(6):e73. Published online 2017 July 24 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e73 |
|
| e75 |
Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancerDown-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer
Wei Jiang, Jia-Jia Pan, Ying-Hui Deng, Mei-Rong Liang, Li-Hua YaoWei Jiang, Jia-Jia Pan, Ying-Hui Deng, Mei-Rong Liang, Li-Hua Yao
KMSID: 1093862 J Gynecol Oncol. 2017;28(6):e75. Published online 2017 November 4 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e75 |
|
| e76 |
Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committeeAssessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee
Shogo Shigeta, Satoru Nagase, Mikio Mikami, Masae Ikeda, Masako Shida, Isao Sakaguchi, Norichika Ushioda, Fumiaki Takahashi, Wataru Yamagami, Nobuo Yaegashi, Yasuhiro Udagawa, Hidetaka KatabuchiShogo Shigeta, Satoru Nagase, Mikio Mikami, Masae Ikeda, Masako Shida, Isao Sakaguchi, Norichika Ushioda, Fumiaki Takahashi, Wataru Yamagami, Nobuo Yaegashi, Yasuhiro Udagawa, Hidetaka Katabuchi
KMSID: 1093863 J Gynecol Oncol. 2017;28(6):e76. Published online 2017 November 4 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e76 |
|
| e77 |
Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinomaPrognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma
Jun Zhu, Hao Wen, Rui Bi, Yong Wu, Xiaohua WuJun Zhu, Hao Wen, Rui Bi, Yong Wu, Xiaohua Wu
KMSID: 1093864 J Gynecol Oncol. 2017;28(6):e77. Published online 2017 November 4 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e77 |
|
| e78 |
Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterusComparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus
Vakkas Korkmaz, Mehmet Mutlu Meydanli, Ibrahim Yalçın, Mustafa Erkan Sarı, Hanifi Sahin, Eda Kocaman, Ali Haberal, Polat Dursun, Tayfun Güngör, Ali AyhanVakkas Korkmaz, Mehmet Mutlu Meydanli, Ibrahim Yalçın, Mustafa Erkan Sarı, Hanifi Sahin, Eda Kocaman, Ali Haberal, Polat Dursun, Tayfun Güngör, Ali Ayhan
KMSID: 1093865 J Gynecol Oncol. 2017;28(6):e78. Published online 2017 September 2 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e78 |
|
| e79 |
Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasionComparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion
Kanyarat KatanyooKanyarat Katanyoo
KMSID: 1093866 J Gynecol Oncol. 2017;28(6):e79. Published online 2017 August 29 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e79 |
|
| e80 |
Nutritional status, cachexia, and anorexia in women with peritoneal metastasis and intraperitoneal chemotherapy: a longitudinal analysisNutritional status, cachexia, and anorexia in women with peritoneal metastasis and intraperitoneal chemotherapy: a longitudinal analysis
Ziad Hilal, Günther A. Rezniczek, Robert Klenke, Askin Dogan, Clemens B. TempferZiad Hilal, Günther A. Rezniczek, Robert Klenke, Askin Dogan, Clemens B. Tempfer
KMSID: 1093868 J Gynecol Oncol. 2017;28(6):e80. Published online 2017 September 2 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e80 |
|
| e81 |
Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based studyEarly-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study
San-Gang Wu, Jia-Yuan Sun, Zhen-Yu He, Qiong-Hua Chen, Juan ZhouSan-Gang Wu, Jia-Yuan Sun, Zhen-Yu He, Qiong-Hua Chen, Juan Zhou
KMSID: 1093869 J Gynecol Oncol. 2017;28(6):e81. Published online 2017 September 8 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e81 |
|
| e82 |
Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancerSurgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer
Chirag A. Shah, Tiffany Beck, John B. Liao, Nadia V. Giannakopoulos, Dan Veljovich, Pam PaleyChirag A. Shah, Tiffany Beck, John B. Liao, Nadia V. Giannakopoulos, Dan Veljovich, Pam Paley
KMSID: 1093870 J Gynecol Oncol. 2017;28(6):e82. Published online 2017 September 12 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e82 |
|
| e83 |
Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematicallyIdentification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically
Chuandi Men, Hongjuan Chai, Xumin Song, Yue Li, Huawen Du, Qing RenChuandi Men, Hongjuan Chai, Xumin Song, Yue Li, Huawen Du, Qing Ren
KMSID: 1093871 J Gynecol Oncol. 2017;28(6):e83. Published online 2017 September 8 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e83 |
|
| e84 |
Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancerImpact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer
Jack M. Qian, John M. Stahl, Melissa R. Young, Elena Ratner, Shari DamastJack M. Qian, John M. Stahl, Melissa R. Young, Elena Ratner, Shari Damast
KMSID: 1093872 J Gynecol Oncol. 2017;28(6):e84. Published online 2017 September 11 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e84 |
|
| e85 |
Survival of gynecological cancers in Turkey: where are we at?Survival of gynecological cancers in Turkey: where are we at?
Murat Gultekin, Selin Dundar, Irem Kucukyildiz, Mujdegul Zayifoglu Karaca, Guledal Boztas, Semra Hatice Turan, Ezgi Hacikamiloglu, Bekir KeskinkilicMurat Gultekin, Selin Dundar, Irem Kucukyildiz, Mujdegul Zayifoglu Karaca, Guledal Boztas, Semra Hatice Turan, Ezgi Hacikamiloglu, Bekir Keskinkilic
KMSID: 1093873 J Gynecol Oncol. 2017;28(6):e85. Published online 2017 November 4 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e85 |
|
| e86 |
Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: a systematic review and meta-analysisTransvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: a systematic review and meta-analysis
Juan Luis Alcázar, Begoña Gastón, Beatriz Navarro, Rocío Salas, Juana Aranda, Stefano GuerrieroJuan Luis Alcázar, Begoña Gastón, Beatriz Navarro, Rocío Salas, Juana Aranda, Stefano Guerriero
KMSID: 1093874 J Gynecol Oncol. 2017;28(6):e86. Published online 2017 September 8 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e86 |
|
| e91 |
Safety of fertility-sparing surgery for stage I ovarian clear cell carcinomaSafety of fertility-sparing surgery for stage I ovarian clear cell carcinoma
Jeong-Yeol ParkJeong-Yeol Park
KMSID: 1094343 J Gynecol Oncol. 2017;28(6):e91. Published online 2017 October 11 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e91 |
|
| e92 |
Comparing prediction models for lymph node metastasis risk in endometrial cancer: the winner may not take it allComparing prediction models for lymph node metastasis risk in endometrial cancer: the winner may not take it all
Sokbom KangSokbom Kang
KMSID: 1094344 J Gynecol Oncol. 2017;28(6):e92. Published online 2017 October 11 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e92 |
|
| e71 |
Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
Dimitrios Nasioudis, Eloise Chapman-Davis, Melissa K. Frey, Steven S. Witkin, Kevin HolcombDimitrios Nasioudis, Eloise Chapman-Davis, Melissa K. Frey, Steven S. Witkin, Kevin Holcomb
KMSID: 1148299 J Gynecol Oncol. 2017;28(6):e71. Published online 2017 July 3 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e71 |
|
| e75 |
Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancerDown-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer
Wei Jiang, Jia-Jia Pan, Ying-Hui Deng, Mei-Rong Liang, Li-Hua YaoWei Jiang, Jia-Jia Pan, Ying-Hui Deng, Mei-Rong Liang, Li-Hua Yao
KMSID: 1148302 J Gynecol Oncol. 2017;28(6):e75. Published online 2017 August 1 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e75 |
|
| e76 |
Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committeeAssessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee
Shogo Shigeta, Satoru Nagase, Mikio Mikami, Masae Ikeda, Masako Shida, Isao Sakaguchi, Norichika Ushioda, Fumiaki Takahashi, Wataru Yamagami, Nobuo Yaegashi, Yasuhiro Udagawa, Hidetaka KatabuchiShogo Shigeta, Satoru Nagase, Mikio Mikami, Masae Ikeda, Masako Shida, Isao Sakaguchi, Norichika Ushioda, Fumiaki Takahashi, Wataru Yamagami, Nobuo Yaegashi, Yasuhiro Udagawa, Hidetaka Katabuchi
KMSID: 1148300 J Gynecol Oncol. 2017;28(6):e76. Published online 2017 August 18 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e76 |
|
| e77 |
Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinomaPrognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma
Jun Zhu, Hao Wen, Rui Bi, Yong Wu, Xiaohua WuJun Zhu, Hao Wen, Rui Bi, Yong Wu, Xiaohua Wu
KMSID: 1148304 J Gynecol Oncol. 2017;28(6):e77. Published online 2017 August 18 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e77 |
|
| e85 |
Survival of gynecological cancers in Turkey: where are we at?Survival of gynecological cancers in Turkey: where are we at?
Murat Gultekin, Selin Dundar, Irem Kucukyildiz, Mujdegul Zayifoglu Karaca, Guledal Boztas, Semra Hatice Turan, Ezgi Hacikamiloglu, Bekir KeskinkilicMurat Gultekin, Selin Dundar, Irem Kucukyildiz, Mujdegul Zayifoglu Karaca, Guledal Boztas, Semra Hatice Turan, Ezgi Hacikamiloglu, Bekir Keskinkilic
KMSID: 1148303 J Gynecol Oncol. 2017;28(6):e85. Published online 2017 September 9 DOI: http://dx.doi.org/10.3802/jgo.2017.28.e85 |
|
